Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | SAR428926 |
Synonyms | |
Therapy Description |
SAR428926 is a antibody-drug conjugate that contains an anti-lysosome-associated membrane protein 1 (LAMP1) monoclonal antibody linked to the cytotoxic anti-microtubule agent DM4, which inhibits growth of LAMP1-expressing tumor cells (NCI Drug Dictionary). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
SAR428926 | SAR428926 is a antibody-drug conjugate that contains an anti-lysosome-associated membrane protein 1 (LAMP1) monoclonal antibody linked to the cytotoxic anti-microtubule agent DM4, which inhibits growth of LAMP1-expressing tumor cells (NCI Drug Dictionary). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT02575781 | Phase I | SAR428926 | A Study of SAR428926 in Patients With Advanced Solid Tumors | Completed | FRA | ESP | DNK | 0 |